About Immuno
Aims
Immuno [ISSN 2673-5601] provides an advanced forum for studies related to basic and clinical immunology research. It publishes reviews, regular research papers, conference reports and communications as well as Special Issues on particular subjects.
The aim of Immuno is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, the journal has no restrictions regarding the maximum length of papers. Full experimental details should be provided so that the results can be reproduced. We also encourage the publication of timely reviews and commentaries on topics of interest to the immunology community. Immuno requires authors to publish all experimental controls and make full datasets available where possible (see the guidelines on Supplementary Materials and references to unpublished data).
Scope
The scope of Immuno covers a broad range of immunology topics, including the following:
- Innate immunity;
- Acquired immunity;
- Synthetic immunity;
- Structural immunology;
- Immunogenetics, immunogenomics, immunoproteomics, immunometabolomics;
- Infectious immunology and vaccines;
- Cancer immunology;
- Immunotherapy;
- Autoimmunity and immunoregulation;
- Developmental immunology;
- Immunodeficiency;
- Reproductive immunology;
- Transplantation immunology;
- Immunodermatology;
- Mucosal immunology;
- Neuroimmunology;
- Immunopathology and immunohistology;
- Clinical/Translational immunology.
Immuno accepts submissions that provide a thorough understanding of these areas, offering insights into the body's response to pathogens, artificial immune responses, molecular components, genetics, infectious diseases, cancer treatment, self-antigen response, developmental disorders, fertility, organ transplantation, skin interactions, mucosal tissues, nervous system interactions, disease analysis, and application of immunology in clinical settings.
MDPI Publication Ethics Statement
MDPI is a member of the Committee on Publication Ethics (COPE).
MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add
high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate
authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in
such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.
Book Reviews
Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.
MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland
Copyright / Open Access
Articles published in Immuno will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:
Reprints may be ordered. Please contact for more information on how to order reprints. Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is . For further MDPI contacts, see here.Reprints
Announcement and Advertisement
Editorial Office
Contact us
